Munich Re Insiders Back the Stock Near a 52-Week Low as €3.6bn Amprion Sale Reshapes the Balance Sheet

Five Munich Re insiders purchase stock near €437.50 trough as the reinsurer exits Amprion stake, signaling confidence despite a 14% YTD stock decline.

Five Munich Re executives have stepped up to buy shares with their own money, snapping up stock close to the 52-week trough of €437.50. The insider purchases come as the reinsurance heavyweight executes a major portfolio shift by offloading its stake in grid operator Amprion to RWE for €3.6bn. For a management team that typically lets buyback programs do the talking, this direct personal commitment sends a clear signal about their confidence in the company’s underlying earnings power.

RWE will increase its holding in Amprion from 25.1% to 55% by acquiring the additional shares from the M31 consortium, which includes Munich Re’s asset manager Meag, alongside Talanx and Swiss Life Asset Managers. The Essen-based utility has already closed a €4bn capital increase to fund the deal, placing 74.4 million new shares at €54 each with institutional investors. Amprion, which supplies 29 million customers across seven German states, will retain its operational independence despite the change in control. The transaction is expected to close by the end of September 2026.

The Amprion exit marks a deliberate redeployment of capital at Munich Re, even as the core reinsurance business continues to deliver strong operating results. First-quarter net profit hit €1.7bn, pushing earnings per share to €13.41 from €8.34 a year earlier. Management is sticking to its full-year profit target of €6.3bn, with the solvency ratio standing at a comfortable 292% – well above the internal threshold. Yet the stock has failed to reflect that momentum, losing roughly 14% since the start of the year and trading at €471.50, nearly 11% below its 200-day moving average of €528.

Alongside the insider buying, the company has been aggressively repurchasing its own shares. The buyback programme has now scooped up more than one million shares, including almost 170,000 that were bought in the middle of June alone. The goal is to steadily increase earnings per share over time by reducing the share count.

Analysts see considerable upside from current levels. The consensus price target stands at €564.57, implying potential gains of about 18% from the present share price. Dividend expectations are also rising: the market forecasts a payout of €25.65 per share for 2026, up from €24.00 for 2025.

The immediate direction of the stock will hinge on two variables before the half-year report on 7 August. First, how pricing evolves during the July renewal season for reinsurance contracts. Second, the trajectory of the Atlantic hurricane season, which will largely determine the claims burden Munich Re faces in the second half. The Amprion sale adds a further dimension: the loss of a steady cash contribution from the infrastructure stake will need to be offset by stronger returns from the core reinsurance portfolio.